Take part in a paid clinical trial

The study drug is a new medicine being developed to potentially treat type 2 inflammation. Type 2 inflammation is a specific type of response by the body’s immune system. While it’s meant to protect us, in some people it can become overactive and contribute to certain long-term health conditions. These include asthma and chronic obstructive pulmonary disease (COPD), which affect breathing; atopic dermatitis, also known as eczema, which causes dry, itchy skin; and chronic rhinosinusitis with nasal polyps, a condition that leads to long-lasting sinus problems and growths in the nose. Understanding type 2 inflammation can help researchers and doctors find better ways to treat these conditions and improve quality of life for people who live with them.  

Your involvement contributes to making future treatments more targeted, accessible, and patient-friendly—potentially helping thousands of people around the world. It’s a meaningful way to support medical progress and make a lasting impact on the lives of others. 

This study is testing a new drug that is being developed to help people with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease. While there are treatments already available, many of them only target one part of the immune system and don’t fully address all aspects of the disease. For example, current therapies often don’t treat the scarring (called fibrosis) that can build up in the bowel over time, and they may not fully heal the lining of the gut. Some treatments also stop working after a while or cause side effects that make long-term use difficult.

This study is investigating a potential treatment for people living with chronic kidney disease. This is a healthy volunteer Japanese participant study.

Chronic kidney disease (CKD) is a long-term condition where the kidneys gradually lose their ability to filter waste and excess fluids from the blood. This can lead to a buildup of toxins in the body, causing health issues such as fatigue, swelling, and high blood pressure. CKD often develops slowly over time, sometimes without noticeable symptoms in the early stages, and is commonly linked to conditions like diabetes and hypertension. While it cannot always be cured, early detection and management can help slow its progression, improve quality of life, and reduce the risk of serious complications. 

Join our flu vaccine study and get protected this season while helping advance important research. Influenza affects millions of people every year, and we’re working to understand how flu vaccines perform in real-world conditions.

By participating, you’ll receive your seasonal flu shot at no cost and contribute to research that could improve future vaccines and protect communities everywhere. It’s simple, sign up online, book your appointment, and get vaccinated while making a meaningful impact on public health. Current flu vaccines don’t always match the flu strains that are circulating, so their effectiveness can vary. Your involvement matters, and together we can build stronger protection against flu.